Brief: India's Suven Life Sciences Gets Product Patents In Europe, South Korea
16/07/2018 06:45
July 16 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS SECURES PRODUCT PATENTS IN EUROPE AND SOUTH KOREA
* PRODUCT PATENTS RELATES TO NEW CHEMICAL ENTITIES FOR
TREATMENT
OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
Source text - https://bit.ly/2LavZx1
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant